Search results
Showing 91 to 105 of 355 results for covid
Specialty guides for patient management during the COVID 19 pandemicICON for midwives during the coronaviruspandemic"Babies...
in their services. A further challenge related to the outbreak of Coronavirus which palpably impacted clinical services in...
standard care or conventional oxygen therapy for people in hospital with COVID-19 and respiratory failure when it is agreed...
O2matic PRO 100 for optimising oxygen treatment in respiratory conditions (MIB308)
NICE has developed a medtech innovation briefing (MIB) on O2matic PRO 100 for optimising oxygen treatment in respiratory conditions .
NICE has developed a medtech innovation briefing (MIB) on Butterfly iQ+ for diagnostic ultrasound imaging .
NG188/2 Question What is the prevalence and incidence of post-COVID-19 syndrome in patients who have received single,...
Find out about the progress made by the health and care system in implementing NICE guidance on end of life care for adults
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
and safety of the combination of casirivimab and imdevimab for treating COVID-19 in people with particular clinical...
Community based approaches to addressing high blood pressure with black African and Caribbean men
available on our website (see below). This project came to an end just as the COVID-19 pandemic started to have an effect...
Evidence-based recommendations on atezolizumab (Tecentriq) for untreated PD-L1-positive locally advanced or metastatic urothelial cancer in adults when cisplatin-containing chemotherapy is unsuitable.
RespiraSense for continuously monitoring respiratory rate (MIB299)
NICE has developed a medtech innovation briefing (MIB) on RespiraSense for continuously monitoring respiratory rate .
NICE has developed a medtech innovation briefing (MIB) on FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome .
Technology appraisal and highly specialised technologies appeals
Technology appraisal and Highly specialised technologies appeals
Our role in the Innovative Licensing and Access Pathway (ILAP)
involvement in the Research to access pathway for investigational drugs for COVID-19 (RAPID C-19) , a...